Search results for "Resorption"

showing 10 items of 141 documents

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature oste…

2015

// Maria Rita Pitari 1 , Marco Rossi 1 , Nicola Amodio 1 , Cirino Botta 1 , Eugenio Morelli 1 , Cinzia Federico 1 , Annamaria Gulla 1 , Daniele Caracciolo 1 , Maria Teresa Di Martino 1 , Mariamena Arbitrio 2 , Antonio Giordano 3, 4 , Pierosandro Tagliaferri 1 , Pierfrancesco Tassone 1, 4 1 Department of Experimental and Clinical Medicine and T. Campanella Cancer Center, Magna Graecia University, S. Venuta University Campus, Catanzaro, Italy 2 ISN-CNR, Roccelletta di Borgia, Catanzaro, Italy 3 Department of Human Pathology and Oncology, University of Siena, Siena, Italy 4 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology,…

Bone diseaseMessengerOsteoclastsTumor Microenvironment3' Untranslated RegionsMultiple myelomaTumorbiologyMesenchymal Stromal CellsRANKLProtein Inhibitors of Activated STATUp-Regulationmedicine.anatomical_structureOncologyRANKLmiRNAsmiR-21MiRNAMultiple MyelomaMiR-21; MiRNAs; Multiple myeloma bone disease; OPG; RANKL; 3' Untranslated Regions; Bone Marrow Cells; Bone Resorption; Cell Adhesion; Cell Line Tumor; Coculture Techniques; HEK293 Cells; Humans; Interleukin-6; Lentivirus; Mesenchymal Stromal Cells; MicroRNAs; Molecular Chaperones; Multiple Myeloma; Osteoclasts; Osteoprotegerin; Protein Inhibitors of Activated STAT; RANK Ligand; RNA Messenger; STAT3 Transcription Factor; Stromal Cells; Tumor Microenvironment; Up-Regulation; OncologyResearch Papermusculoskeletal diseasesSTAT3 Transcription FactorStromal cellBone Marrow CellsBone resorptionCell LineOsteoprotegerinCell Line TumormedicineCell AdhesionHumansRNA MessengerBone Resorptionbusiness.industryInterleukin-6LentivirusRANK LigandOsteoprotegerinMesenchymal Stem Cellsmedicine.diseaseMolecular medicineCoculture TechniquesMicroRNAsmultiple myeloma bone diseaseHEK293 CellsImmunologyCancer researchbiology.proteinRNAOPGBone marrowStromal CellsbusinessMolecular ChaperonesOncotarget
researchProduct

miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone di…

2013

Skeletal homeostasis relies upon a fine tuning of osteoclast (OCLs)-mediated bone resorption and osteoblast (OBLs)-dependent bone formation. This balance is unsettled by multiple myeloma (MM) cells, which impair OBL function and stimulate OCLs to generate lytic lesions. Emerging experimental evidence is disclosing a key regulatory role of microRNAs (miRNAs) in the regulation of bone homeostasis suggesting the miRNA network as potential novel target for the treatment of MM-related bone disease. Here, we report that miR-29b expression decreases progressively during human OCL differentiation in vitro. We found that lentiviral transduction of miR-29b into OCLs, even in the presence of MM cells,…

Bone diseasePhysiologyCellular differentiationCathepsin KClinical BiochemistryGene ExpressionOsteoclastsOsteolysisMMP9Cathepsin KCells CulturedTartrate-resistant acid phosphataseTumorCulturedReceptor Activator of Nuclear Factor-kappa BGenes fosCell DifferentiationOsteoblastCell biologyIsoenzymesmultiple myelomamedicine.anatomical_structureMatrix Metalloproteinase 9osteoclastMatrix Metalloproteinase 2medicine.medical_specialtyfosCellsAcid PhosphataseBiologyCollagen Type IBone resorptionCell LineOsteoclastCell Line TumorInternal medicinemedicineHumansBone ResorptionOsteoblastsmicroRNA.NFATC Transcription FactorsTartrate-Resistant Acid PhosphatasemiR-29bCell Biologymedicine.diseaseActinsMicroRNAsEndocrinologyGenesAcid Phosphatase; Actins; Bone Resorption; Cathepsin K; Cell Differentiation; Cell Line Tumor; Cells Cultured; Collagen Type I; Gene Expression; Genes fos; Humans; Isoenzymes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MicroRNAs; Multiple Myeloma; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteolysis; Receptor Activator of Nuclear Factor-kappa BJournal of Cellular Physiology
researchProduct

Serum and urine markers of type I collagen metabolism in elderly women with high and low bone mineral density.

1996

The serum markers of bone formation (carboxy-terminal propeptide of type I collagen, PICP) and resorption (pyridinoline cross-links containing telopeptide of type I collagen, ICTP), as well as urinary resorption markers, pyridinoline (Pyr) and deoxypyridinoline (Dpyr), were studied in 78-year-old women with high (n = 18) and low (n = 17) bone mineral density (BMD) measured from the calcaneus and tibia. The low-BMD group had higher values for PICP (P = 0 center dot 025), Pyr (P = 0 center dot 001) and Dpyr (P < 0 center dot 001) than the high-BMD group. No inverse relationship between these markers and BMD was, however, observed within the study groups. ICTP, Pyr and Dpyr correlated with eac…

Bone mineralmedicine.medical_specialtyDeoxypyridinolineAgingPyridinolineBone densityClinical BiochemistryGeneral Medicinemusculoskeletal systemBiochemistryResorptionBone remodelingchemistry.chemical_compoundEndocrinologychemistryN-terminal telopeptideBone DensityInternal medicinemedicineHumansFemaleCollagenType I collagenAgedEuropean journal of clinical investigation
researchProduct

Randomized, Double-Blind, Clinically Controlled Trial of Intranasal Calcitonin Treatment in Patients with Hip Fracture

2002

The objective of this study was to evaluate the short-term outcome of intranasal calcitonin treatment of elderly hip fracture patients on pain, bone loss, functional recovery, and length of hospital stay. In addition, we wanted to compare the effect of calcitonin with placebo on fusion of hip fractures treated with internal fixation using a screw or a nail. In a randomized, double-blind, clinically controlled trial, 260 independently living patients (aged 65 years or older) with acute hip fracture were randomly assigned to intranasal calcitonin 200 IU daily for 3 months or matching placebo nasal spray. Analyses were completed on an intention-to-treat basis. Three months after the operation,…

CalcitoninMalemedicine.medical_specialtyVisual analogue scaleEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisPainPlacebolaw.inventionFracture Fixation InternalEndocrinologyDouble-Blind MethodRandomized controlled trialBone DensitylawActivities of Daily LivingFracture fixationmedicineHumansInternal fixationOrthopedics and Sports MedicineBone ResorptionAdministration IntranasalOsteoporosis PostmenopausalAgedPain MeasurementAged 80 and overFracture HealingHip fractureHip Fracturesbusiness.industryLength of Staymedicine.diseaseSurgeryCalcitoninFemalebusinessCalcified Tissue International
researchProduct

Induction of carbonic anhydrase in SaOS-2 cells, exposed to bicarbonate and consequences for calcium phosphate crystal formation.

2013

Ca-phosphate/hydroxyapatite crystals constitute the mineralic matrix of vertebrate bones, while Ca-carbonate dominates the inorganic matrix of otoliths. In addition, Ca-carbonate has been identified in lower percentage in apatite crystals. By using the human osteogenic SaOS-2 cells it could be shown that after exposure of the cells to Ca-bicarbonate in vitro, at concentrations between 1 and 10 mm, a significant increase of Ca-deposit formation results. The crystallite nodules formed on the surfaces of SaOS-2 cells become denser and larger in the presence of bicarbonate if simultaneously added together with the mineralization activation cocktail (β-glycerophosphate/ascorbic acid/dexamethason…

Calcium Phosphatesmedicine.drug_classBicarbonateBiophysicschemistry.chemical_elementBioengineering02 engineering and technologyAscorbic AcidCalciumDexamethasoneCell LineBiomaterials03 medical and health scienceschemistry.chemical_compoundCarbonic anhydrasemedicineEscherichia coliHumansCarbonic anhydrase inhibitorBone ResorptionCarbonic Anhydrase InhibitorsSaos-2 cells030304 developmental biologyCarbonic Anhydrases0303 health sciencesbiologyX-RaysGene Expression Regulation Developmental021001 nanoscience & nanotechnologyPhosphateAscorbic acidUp-RegulationAcetazolamideBicarbonatesMicroscopy ElectronchemistryBiochemistryMechanics of MaterialsGlycerophosphatesCeramics and Compositesbiology.protein0210 nano-technologyAcetazolamidemedicine.drugBiomaterials
researchProduct

PO-146 Multiple myeloma-derived exosomes carry amphiregulin and are responsible for the uncoupled bone remodelling

2018

Introduction Multiple myeloma (MM) is a hematologic malignancy associated with osteolytic bone disease caused by the perturbation of the functional balance between bone resorption and bone formation. Exosomes, nanosize lipoproteic structures, have been recently recognised as a new mechanism of cell to cell communication during tumour growth and progression. We have previously shown that MM-exosomes are involved in osteolytic lesions but the underlying mechanism is still understood. We hypothesise that the epidermal growth factor receptor ligand Amphiregulin (AREG) can be delivered by multiple myeloma-derived exosomes and participate in modulating the response of the bone microenvironment to…

Cancer ResearchChemistryMesenchymal stem cellExosomeBone resorptionMicrovesiclesBone remodelingmedicine.anatomical_structureOncologyAmphiregulinCell cultureOsteoclastmedicineCancer researchESMO Open
researchProduct

Der Einfluss kondensierter Phosphate auf die Eisen-Resorption

1959

Es sollte untersucht werden, ob die kondensierten Phosphate Tetranatriumpyrophosphat, Natriumtripolyphosphat, Hexametaphosphat, Kaliummetaphosphat und Plasmal die Eisenresorption beeintrachtigen. Als Masstab fur diesselbe galten die Hamoglobin- und Erythrocytenregeneration und die Gewichtszunahme anamischer Ratten. Die Anamie wurde durch Phenylhydrazinhydrochlorid-Injektionen bzw. eine eisenarme Ernahrung (Milchdiat) hervorgerufen. Bei den herrschenden Versuchsbedingungen konnte ein nachteiliger Einflus der getesteten Substanzen auf die Eisenresorption nicht nachgewiesen werden. Auf Grund dieser Versuche und allgemeiner Uberlegungen wurde geschlossen, das dies uberhaupt unter physiologische…

ChemistryIron absorptionDrug DiscoveryMolecular MedicineGeneral MedicineMolecular biologyDna packagingGenetics (clinical)Physiological PhenomenonCondensed phosphateResorptionKlinische Wochenschrift
researchProduct

Zur Frage der Resorption von Polyphosphaten

1965

Zur Klarung der Frage nach der Resorption von Polyphosphaten wurden Losungen von32P-markiertem Diphosphat, Triphosphat und einem Natriumpolyphosphat mit 64% P2O5 Ratten mit der Schlundsonde appliziert. Nach einer Verweildauer von 1, 2, 4, 8 und 16 Std dieser Polyphosphate im Magen-Darmtrakt wurden die Ratten dekapitiert und das erhaltene Frischblut radiometrisch und papierchromatographisch untersucht. Im enteiweisten Vollblut konnten nur Monophosphat und AMP nachgewiesen werden, d. h. es wird ausschlieslich anorganisches Monophosphat resorbiert, das durch enzymatische Aufspaltung der Polyphosphate gebildet wird. Dieses Monophosphat wird dann in die organische Bindung der AMP ubergefuhrt und…

ChemistryMedicine (miscellaneous)General MedicineBiochemistryMolecular biologyIntestinal absorptionResorptionPaper chromatographyDrug DiscoveryMolecular MedicineDigestive tractAbsorption (chemistry)Genetics (clinical)Food ScienceNuclear chemistryKlinische Wochenschrift
researchProduct

Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line

2009

Postmenopausal women treated with an isopropanolic extract of Cimicifuga racemosa underwent a decrease in the urinary concentration of N-telopeptides, a marker of bone resorption, and an increase in alkaline phosphatase, a marker of bone formation, at the third month of therapy. Serum from treated women did not modify the activity of alkaline phosphatase or the expression of three genes, runt-related transcription factor-2 (Runx-2), alkaline phosphatase, and osteocalcin, when added to the MC3T3-E1 osteoblastic cell line.

Cimicifugamedicine.medical_specialtyOsteocalcinCore Binding Factor Alpha 1 SubunitOsteoblastic cellBone and BonesCollagen Type IBone resorptionCell Line2-PropanolMiceOsteogenesisInternal medicinemedicineAnimalsHumansProspective StudiesBone ResorptionOsteoblastsbiologyPlant Extractsbusiness.industryCimicifuga racemosaBone markersObstetrics and GynecologyOsteoblastAlkaline PhosphatasePostmenopauseEndocrinologymedicine.anatomical_structureReproductive MedicineCell cultureOsteocalcinbiology.proteinAlkaline phosphataseFemalePeptidesbusinessBiomarkersPhytotherapyFertility and Sterility
researchProduct

Terpenoid treatment in osteoporosis: this is where we have come in research.

2021

Lower bone resistance to load is due to the imbalance of bone homeostasis, where excessive bone resorption, compared with bone formation, determines a progressive osteopenia, leading to a high risk of fractures and consequent pain and functional limitations. Terpenoids, with their activities against bone resorption, have recently received increased attention from researchers. They are potentially more suitable for long-term use compared with traditional therapeutics. In this review of the literature of the past 5 years, we provide comprehensive information on terpenoids, with their anti-osteoporotic effects, highlighting molecular mechanisms that are often in epigenetic key and a possible p…

Endocrinology Diabetes and MetabolismOsteoporosisBioinformaticsBone resorptionBone and BonesFractures BoneEndocrinologyOsteoclastterpenoidsSettore BIO/13 - Biologia ApplicataSettore BIO/10 - Biochimicamedicinebone erosive diseasesHumansBone formationBone ResorptionProgressive osteopeniaepigeneticsbusiness.industryTerpenesOsteoporosis preventionOsteoblastmedicine.diseaseSettore BIO/18 - Geneticamedicine.anatomical_structureosteoclastosteoblastOsteoporosisbusinessTrends in endocrinology and metabolism: TEM
researchProduct